Home > Insider Trading > Filing (0001209191-18-007258)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
860730	Hca Healthcare Inc.	HCA	Services-General Medical & Surgical Hospitals, Nec (8062)	273865930

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1680636	A. Kathryn Torres	One Park Plaza Nashville TN 37203	Svp-Payer Contracting & Align.	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-01-31	4,300	$22.95	4,856	No	4	M	Direct
Common Stock	Acquisiton	2018-01-31	7,750	$37.18	12,606	No	4	M	Direct
Common Stock	Disposition	2018-01-31	5,871	$101.16	6,735	No	4	F	Direct
Common Stock	Disposition	2018-02-02	5,000	$100.93	1,735	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Appreciation Right	Disposition	2018-01-31	4,300	$0.00	4,300	$22.95
Common Stock	Stock Appreciation Right	Disposition	2018-01-31	6,250	$0.00	6,250	$37.18
Common Stock	Stock Appreciation Right	Disposition	2018-01-31	1,500	$0.00	1,500	$37.18
Common Stock	Stock Appreciation Right	Acquisiton	2018-01-31	18,300	$0.00	18,300	$101.16

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2022-02-08	No	4	M	Direct
0		2023-02-06	No	4	M	Direct
4,437		2023-02-06	No	4	M	Direct
18,300	2019-01-31	2028-01-31	No	4	A	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.9256 to $100.9341, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013.
The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014.
The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.
The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019.